Editorial Article: Meet the microspheres helping to deliver rapid, low-cost, low-limit SARS-CoV-2 detection
Take lateral flow diagnostics to the next level with improved sensitivity for the future of IVD
09 Jul 2021
At the beginning of the pandemic, there was a surge in demand for
in vitro diagnostics (IVDs) as COVID-19 spread across the globe. From lateral flow assays to chemiluminescent immunoassays (CLIA) and immunoturbidimetric assays (IT), IVDs come in a variety of forms and can be used for many different applications, including the detection and/or quantification of hormones, antibiotics, autoimmune diseases, and microbial and viral infections such as SARS-CoV-2.
Despite their prevalence in the market, the development of lateral flow assays can be complex, with successful assay development requiring an understanding of multiple scientific disciplines. Most lateral flow assays are designed in one of four formats: sandwich, competitive, inhibition, or serum assays, each p
Highlights from the Virtual Clinical Science Summit 2021
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
How microspheres are helping deliver rapid COVID detection
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
Highlights from the Virtual Clinical Science Summit 2021
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.